← Open Payments lookup

DAVID WILKINS: Open Payments

NPI 1740230200 · MUSKEGON, MI. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.

See the full provider profile for registry, prescribing and billing details.

Industry payments (Sunshine Act)

Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.

$10,276 in 243 payments from 34 companies in 2025. Trend: 2023 $11,618 · 2024 $7,631 · 2025 $10,276

Speaker / faculty: $5,750Food & beverage: $4,273Travel & lodging: $197Education: $56
CompanyPaymentsAmount
Amgen Inc.18$6,369
ABBVIE INC.42$620
Supernus Pharmaceuticals, Inc.26$385
Novo Nordisk Inc16$295
PFIZER INC.16$284
Alkermes, Inc.12$283
AstraZeneca Pharmaceuticals LP7$215
Axsome Therapeutics, Inc.7$193
GlaxoSmithKline, LLC.18$173
Otsuka America Pharmaceutical, Inc.9$160

Products named: REPATHA, Qelbree, ARISTADA, LINZESS, NURTEC ODT, FARXIGA, CAPLYTA, Ozempic.

Industry payments across MI — which companies pay providers there.